Genetics of Monosomy 7 and Del(7q) in MDS Informs Potential Therapeutic Targets

生物 遗传学 杂合子丢失 单体 7号染色体(人类) 基因 突变 体细胞 种系突变 等位基因 癌症研究 染色体 核型
作者
Cassandra M Kerr,Vera Ademà,Wencke Walter,Stephan Hütter,Christina Snider,Yasunobu Nagata,Manja Meggendorfer,Claudia Haferlach,Valeria Visconte,Mikkael A. Sekeres,Thomas LaFramboise,Torsten Haferlach,Jaroslaw P. Maciejewski
出处
期刊:Blood [Elsevier BV]
卷期号:134 (Supplement_1): 1703-1703 被引量:3
标识
DOI:10.1182/blood-2019-126866
摘要

Monosomy (-7) and deletions of the long arm of chromosome 7 (del7q) are frequently found in patients with myeloid neoplasms, suggesting a crucial role of this region in disease pathogenicity. -7/del7q conveys a poor prognosis and no targeted therapies exist for patients harboring this defect. We previously characterized the most common deleted regions (CDR) of del7q, including 7q22, 7q34, and 7q35-36, as well as micro deletions on del7q indicative of pathogenic genes. Unlike del5q, -7/del7q is affected both by deletions and somatic UPD, suggesting that loss of heterozygosity (LOH), rather than or in addition to haploinsufficient (HI) gene expression, may play a pathogenic role. Previous studies identified possible driver genes contributing to the pathogenesis of -7/del7q including CUX1, EZH2, LUC7L2, MLL3, and SAMD9/9L. Some of these genes may be affected by somatic mutations in hemizygous (LUC7L2), or homozygous (EZH2) configurations while others are affected by germ line (GL) mutations wherein a disease-prone allele is eliminated upon somatic acquisition of -7/del7q. The pathogenic mechanisms driving evolution of -7/del7q neoplasms, though, have not been clarified and specific therapies similar to lenalidomide in del5q have not been developed yet. The outstanding open questions include: i) the rank of -7/del7q in the clonal hierarchy; ii) genetic predispositions to -7/del7q; iii) new important genes affected by LOH or HI; iv) genetic differences between -7 and del7q; and v) co-associated somatic hits. We performed a complex molecular analysis of -7/del7q patients (N=316) using NGS: 67% with -7 (211/316) and 33% with del7q (105/316). First we performed analyses of clonal architecture using an allelic imbalance pipeline which facilitated reconstruction of clonal hierarchy. In 58% of patients -7/del7q was an ancestral lesion, while in 42% it was preceded by somatic hits such as TP53 (60%), IDH1/2 (30%), and DNMT3A (20%). The frequency of a chr7 abnormality as ancestral vs. secondary was no different in -7 vs. del7q. We then studied somatic hits associated with -7/del7q. The most commonly mutated genes were TP53 (43%), TET2 (17%), DNMT3A (15%), and ASXL1 (11%) and the most frequent additional lesion was del5q (30%). About 40% of -7 and 58% of del7q occurred in the context of complex karyotype (CK). We then compared various clinical and mutational features of patients with -7 vs. del7q: -7 was significantly associated with +8 (p=.002), while del7q was associated with CK (p=.004). Isolated -7/del7q was associated with mutations in TET2 (35% vs. 10%, p<.001), DNMT3A (23% vs. 11%, p=.03), ASXL1 (18% vs. 4%, p<.001), and SETBP1 (18% vs. 3%, p<.001). -7/del7q in a CK was strongly associated with a worse prognosis (p=.003) and TP53 mutations (66% vs. 6% isolated -7/del7q, p<.001). Focusing on genes located on chr7, hemizygous mutations were found in CUX1 (2% vs. 4% heterozygous, het), EZH2 (5% vs. 5% het), and LUC7L2 (2% vs. 0.4% het). Mutated genes on -7/del7 not previously described as being associated with MDS included SDK1 (n=13), and CD36 (n=13), among others. Among our patients, 2% harbored SAMD9/9L and <1% heterozygous Fanconi Anemia Tier 1 GL mutations. RNA-seq was used to identify HI genes in the CDR. We defined HI expression of a gene in a given patient as having expression < 25th percentile of diploid MDS patients. Based on this criterion, 60% of genes were HI in at least half of the patients. Of known -7/del7q genes, we confirmed HI in CUX1 (79%), EZH2 (83%), LUC7L2 (63%), MLL3 (76%), SAMD9/9L (34% / 53%) among -7/del7q. Expression of AQP1, KEL, and KCNH2 fulfilled the working definition of HI in diploid cases. Out of all 358 (100%) HI genes, 75% were HI in 63%, 50% in 73%, and 25% in 89% of -7/del7q patients, a diversity that could contribute to clinical heterogeneity. We also identified genes not previously reported to be HI, including PSM2 (97%), MDH2 (92%), SSBP1 (92%), and CUL1 (91%) on 7q and SNX10 (100%) and IKZF1 (96%) on 7p. In sum, we showed the clonal hierarchy of -7/del7q and identified a number of genes that were previously not reported to be HI in -7/del7q patients. We are evaluating expression patterns to establish a minimal expression signature of -7/del7q. Further investigation of these genes could reveal their pathogenesis in myeloid disease. Other contributions from our group (V Adema et al, ASH2019) include implication of IKZF1 and CUL1 as potential drug targets in -7/del7q. Disclosures Walter: MLL Munich Leukemia Laboratory: Employment. Hutter:MLL Munich Leukemia Laboratory: Employment. Meggendorfer:MLL Munich Leukemia Laboratory: Employment. Haferlach:MLL Munich Leukemia Laboratory: Employment, Equity Ownership. Sekeres:Syros: Membership on an entity's Board of Directors or advisory committees; Millenium: Membership on an entity's Board of Directors or advisory committees; Celgene: Membership on an entity's Board of Directors or advisory committees. Haferlach:MLL Munich Leukemia Laboratory: Employment, Equity Ownership. Maciejewski:Alexion: Consultancy; Novartis: Consultancy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
上官若男的应助被小明同学采纳,获得10
1秒前
1秒前
2秒前
齐是发布了新的文献求助10
3秒前
干净绫完成签到,获得积分10
3秒前
常樂完成签到 ,获得积分10
3秒前
拿铁完成签到 ,获得积分10
3秒前
康子浩发布了新的文献求助10
4秒前
4秒前
Ava的应助被路遥采纳,获得10
4秒前
嘻嘻完成签到 ,获得积分10
4秒前
我要吃饭完成签到,获得积分10
4秒前
张大大发布了新的文献求助10
5秒前
香菜炒土豆完成签到,获得积分10
5秒前
小二郎的应助被谨慎的秋烟采纳,获得10
6秒前
仲棠完成签到,获得积分20
6秒前
null的应助被PO采纳,获得10
6秒前
7秒前
Lucas的应助被akakns采纳,获得10
7秒前
奋斗的科研新瓜蛋完成签到,获得积分20
7秒前
研友_VZG7GZ的应助被Ulysses采纳,获得10
8秒前
Mmm发布了新的文献求助10
8秒前
8秒前
8秒前
wanci的应助被bayes618采纳,获得10
8秒前
whj完成签到,获得积分10
10秒前
10秒前
小明同学发布了新的文献求助10
10秒前
mmmm发布了新的文献求助310
10秒前
ss发布了新的文献求助10
10秒前
雪山大地发布了新的文献求助10
11秒前
秋风的应助被康子浩采纳,获得10
11秒前
南风发布了新的文献求助40
14秒前
14秒前
小马甲的应助被Enb采纳,获得10
14秒前
14秒前
15秒前
干饭啦发布了新的文献求助10
15秒前
A2311完成签到,获得积分10
15秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163746
求助须知:如何正确求助?哪些是违规求助? 9557874
关于积分的说明 21742203
捐赠科研通 7754407
什么是DOI,文献DOI怎么找? 3428345
关于科研通互助平台的介绍 2553000
邀请新用户注册赠送积分活动 2472945